Skip to main content
Premium Trial:

Request an Annual Quote

Illumina Gets NIAID Grant for Proteomic Arrays

NEW YORK, Aug 12 (GenomeWeb News) - Illumina announced today that it has received a $1.2 million Phase 2 Small Business Innovative Research grant from the National Institute of Allergy and Infectious Diseases to support development of the firm's proteomic arrays.


The San Diego-based firm currently sells its BeadArray platforms for SNP genotyping and gene expression. The new proteomics arrays will be based on the same bead-based technology.